Cambridge Healthtech Institute’s 4th Annual

Antibodies Against Membrane Protein Targets

New Strategies and Technologies to Accelerate the Development of Biotherapeutics Against Complex GPCR and Ion Channel Targets

13 November 2025 ALL TIMES WET (GMT/UTC)


The 2025 Antibodies Against Membrane Proteins track will explore the latest strategies for developing antibodies targeting complex membrane proteins, a crucial area for therapeutic innovation. This track will highlight advances in mechanistic understanding across diverse disease areas, including cancer, neuroscience, and metabolic disorders, with a focus on overcoming long-standing challenges in drug discovery. Attendees will explore the integration of AI/ML tools in this space and discuss cutting-edge screening methods, structural analysis, and novel approaches for addressing resistance mechanisms. By bringing together experts in antibody engineering, structural biology, and computational modeling, this track aims to advance the field toward more precise and effective therapies.

Recommended Short Course*
Monday, 10 November, 14:00 – 17:00
SC2: Best Practices for Targeting GCPRs, Ion Channels, and Transporters with Monoclonal Antibodies
*Separate registration required. See short courses page for details. All short courses take place in-person only.






For more details on the conference, please contact:

Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 207-329-2964
Email: ksimmons@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com